HIPO Strangle Strategy

HIPO (Hippo Holdings Inc.), in the Financial Services sector, (Insurance - Specialty industry), listed on NYSE.

Hippo Holdings Inc. provides home protection insurance in the United States and the District of Columbia. Its insurance products include homeowners' insurance against risks of fire, wind, and theft; and commercial and personal lines of products. The company distributes insurance products and services through its technology platform; and offers its policies online, over the phone, or through licensed insurance agents. It provides care and protection for homeowners, as well as operates an integrated home protection platform. The company is headquartered in Palo Alto, California.

HIPO (Hippo Holdings Inc.) trades in the Financial Services sector, specifically Insurance - Specialty, with a market capitalization of approximately $686.8M, a trailing P/E of 6.06, a beta of 1.54 versus the broader market, a 52-week range of 21.8-38.98, average daily share volume of 123K, a public-listing history dating back to 2021, approximately 478 full-time employees. These structural characteristics shape how HIPO stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 1.54 indicates HIPO has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position. The trailing P/E of 6.06 is on the value side, where IV often compresses outside event windows because forward growth expectations are already discounted into the share price.

What is a strangle on HIPO?

A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.

Current HIPO snapshot

As of May 15, 2026, spot at $26.02, ATM IV 58.60%, IV rank 13.22%, expected move 16.80%. The strangle on HIPO below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.

Why this strangle structure on HIPO specifically: HIPO IV at 58.60% is on the cheap side of its 1-year range, which favors premium-buying structures like a HIPO strangle, with a market-implied 1-standard-deviation move of approximately 16.80% (roughly $4.37 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated HIPO expiries trade a higher absolute premium for lower per-day decay. Position sizing on HIPO should anchor to the underlying notional of $26.02 per share and to the trader's directional view on HIPO stock.

HIPO strangle setup

The HIPO strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With HIPO near $26.02, the first option leg uses a $27.32 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed HIPO chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 HIPO shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Call$27.32N/A
Buy 1Put$24.72N/A

HIPO strangle risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.

HIPO strangle payoff curve

Modeled P&L at expiration across a range of underlying prices for the strangle on HIPO. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use strangle on HIPO

Strangles on HIPO are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the HIPO chain.

HIPO thesis for this strangle

The market-implied 1-standard-deviation range for HIPO extends from approximately $21.65 on the downside to $30.39 on the upside. A HIPO long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current HIPO IV rank near 13.22% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on HIPO at 58.60%. As a Financial Services name, HIPO options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to HIPO-specific events.

HIPO strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. HIPO positions also carry Financial Services sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move HIPO alongside the broader basket even when HIPO-specific fundamentals are unchanged. Always rebuild the position from current HIPO chain quotes before placing a trade.

Frequently asked questions

What is a strangle on HIPO?
A strangle on HIPO is the strangle strategy applied to HIPO (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With HIPO stock trading near $26.02, the strikes shown on this page are snapped to the nearest listed HIPO chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are HIPO strangle max profit and max loss calculated?
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the HIPO strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 58.60%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a HIPO strangle?
The breakeven for the HIPO strangle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current HIPO market-implied 1-standard-deviation expected move is approximately 16.80%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a strangle on HIPO?
Strangles on HIPO are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the HIPO chain.
How does current HIPO implied volatility affect this strangle?
HIPO ATM IV is at 58.60% with IV rank near 13.22%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

Related HIPO analysis